What smart money is saying about Ionis Pharmaceuticals Inc.
IONS
No fund has written a full thesis on Ionis Pharmaceuticals Inc. in our archive, but 2 fund letters report a position in it — most recently Baron Health Care Fund in June 2026.
Get an email when a fund writes about it
2
Reported positions
1
Bought
1
Sold
3
Letters
Position history
Every position in Ionis Pharmaceuticals Inc. on record in the archive was reported in Q2 2026, across 2 fund letters — 1 opened or added to the position, 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 2 | 1 | 1 | 0 |
Fund activity · 2 positions · 2 moves
- TrimmedBaron Health Care FundJune 2026
“Top net sales for the quarter Net Amount Sold ($M) AstraZeneca PLC 3.0 Ionis Pharmaceuticals, Inc. 2.3 Apogee Therapeutics, Inc. 2.0 Terns Pharmaceuticals, Inc. 1.8 Stryker Corporation 1.7 We reduced our positions in AstraZeneca PLC and Ionis Pharmaceuticals, Inc. due to valuation.”
Ionis Pharmaceuticals Inc. - June 2026
“We continued to build our position in Ionis Pharmaceuticals Inc., a commercial-stage biotechnology company focused on neurology and cardiovascular indications.”
Ionis Pharmaceuticals Inc.
Also mentioned · 1
These funds discuss Ionis Pharmaceuticals Inc. — as a competitor, benchmark or comparable — without disclosing a position in it.
- March 2026
“New to the sector this quarter was Ionis Pharmaceuticals Inc., a commercial-stage biotechnology company focused on neurology and cardiovascular indications.”
Ionis Pharmaceuticals Inc.
Read the letters behind these Ionis Pharmaceuticals Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger